Izlaganje sa skupa

WEIGHT GAIN - AS POSSIBLE PREDICTOR OF METABOLIC SYNDROME

Tanja Grahovac ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Klementina Ružić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Elizabeta Dadić-Hero ; Department of Social Medicine and Epidemiology, School of Medicine, Rijeka, Croatia
Dubravka Šepić-Grahovac ; Policlinic for Neurology and Psychiatry "Interneuron", Rijeka, Croatia
Vladimir Sabljić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia

Sažetak

Rapid weight gain among patients with mental disorders can further compound psychological distress and negatively influence
compliance. Weight gain associated with treatment with atypical antipsychotic medication has been widely recognized as a risk
factor for the development of diabetes type II and cardiovascular diseases.
This paper describes a 33-year old female patient treated for schizoaffective disorder. Within two months after introducing
quetiapine the patient experienced considerable weight gain amounting to 19 kg. The replacement of antipsychotic during inpatient
psychiatric care resulted in weight loss.

Ključne riječi

metabolic syndrome; quetiapine; weight gain

Hrčak ID:

76548

URI

https://hrcak.srce.hr/76548

Datum izdavanja:

31.3.2011.

Posjeta: 1.298 *